ArticleInternational journal of biological sciences2023

Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis.

Mingbo Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.